
Forecast for a SARS-CoV-2 vaccine candidate demonstrating a 70% or better efficacy
Author(s) -
NA Dan Sluder
Publication year - 2020
Language(s) - English
DOI - 10.34235/af479eb7-3f2e-4fed-8c14-181566de6621
Subject(s) - covid-19 , virology , medicine , infectious disease (medical specialty) , outbreak , disease